A clinically attenuated double-mutant of porcine reproductive and respiratory syndrome virus-2 that does not prompt overexpression of proinflammatory cytokines during co-infection with a secondary pathogen

Porcine reproductive and respiratory syndrome virus (PRRSV) is known to suppress the type I interferon (IFNs-α/β) response during infection. PRRSV also activates the NF-κB signaling pathway, leading to the production of proinflammatory cytokines during infection. In swine farms, co-infections of PRR...

Full description

Saved in:
Bibliographic Details
Published inPLoS pathogens Vol. 20; no. 3; p. e1012128
Main Authors Su, Chia-Ming, Kim, Jineui, Tang, Junyu, Hung, Yu Fan, Zuckermann, Federico A., Husmann, Robert, Roady, Patrick, Kim, Jiyoun, Lee, Young-Min, Yoo, Dongwan
Format Journal Article
LanguageEnglish
Published United States Public Library of Science 28.03.2024
Public Library of Science (PLoS)
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Porcine reproductive and respiratory syndrome virus (PRRSV) is known to suppress the type I interferon (IFNs-α/β) response during infection. PRRSV also activates the NF-κB signaling pathway, leading to the production of proinflammatory cytokines during infection. In swine farms, co-infections of PRRSV and other secondary bacterial pathogens are common and exacerbate the production of proinflammatory cytokines, contributing to the porcine respiratory disease complex (PRDC) which is clinically a severe disease. Previous studies identified the non-structural protein 1β (nsp1β) of PRRSV-2 as an IFN antagonist and the nucleocapsid (N) protein as the NF-κB activator. Further studies showed the leucine at position 126 (L126) of nsp1β as the essential residue for IFN suppression and the region spanning the nuclear localization signal (NLS) of N as the NF-κB activation domain. In the present study, we generated a double-mutant PRRSV-2 that contained the L126A mutation in the nsp1β gene and the NLS mutation (ΔNLS) in the N gene using reverse genetics. The immunological phenotype of this mutant PRRSV-2 was examined in porcine alveolar macrophages (PAMs) in vitro and in young pigs in vivo. In PAMs, the double-mutant virus did not suppress IFN-β expression but decreased the NF-κB-dependent inflammatory cytokine productions compared to those for wild-type PRRSV-2. Co-infection of PAMs with the mutant PRRSV-2 and Streptococcus suis (S . suis) also reduced the production of NF-κB-directed inflammatory cytokines. To further examine the cytokine profiles and the disease severity by the mutant virus in natural host animals, 6 groups of pigs, 7 animals per group, were used for co-infection with the mutant PRRSV-2 and S . suis . The double-mutant PRRSV-2 was clinically attenuated, and the expressions of proinflammatory cytokines and chemokines were significantly reduced in pigs after bacterial co-infection. Compared to the wild-type PRRSV-2 and S . suis co-infection control, pigs coinfected with the double-mutant PRRSV-2 exhibited milder clinical signs, lower titers and shorter duration of viremia, and lower expression of proinflammatory cytokines. In conclusion, our study demonstrates that genetic modification of the type I IFN suppression and NF-κB activation functions of PRRSV-2 may allow us to design a novel vaccine candidate to alleviate the clinical severity of PRRS-2 and PRDC during bacterial co-infection.
AbstractList Porcine reproductive and respiratory syndrome virus (PRRSV) is known to suppress the type I interferon (IFNs-α/β) response during infection. PRRSV also activates the NF-κB signaling pathway, leading to the production of proinflammatory cytokines during infection. In swine farms, co-infections of PRRSV and other secondary bacterial pathogens are common and exacerbate the production of proinflammatory cytokines, contributing to the porcine respiratory disease complex (PRDC) which is clinically a severe disease. Previous studies identified the non-structural protein 1β (nsp1β) of PRRSV-2 as an IFN antagonist and the nucleocapsid (N) protein as the NF-κB activator. Further studies showed the leucine at position 126 (L126) of nsp1β as the essential residue for IFN suppression and the region spanning the nuclear localization signal (NLS) of N as the NF-κB activation domain. In the present study, we generated a double-mutant PRRSV-2 that contained the L126A mutation in the nsp1β gene and the NLS mutation (ΔNLS) in the N gene using reverse genetics. The immunological phenotype of this mutant PRRSV-2 was examined in porcine alveolar macrophages (PAMs) in vitro and in young pigs in vivo. In PAMs, the double-mutant virus did not suppress IFN-β expression but decreased the NF-κB-dependent inflammatory cytokine productions compared to those for wild-type PRRSV-2. Co-infection of PAMs with the mutant PRRSV-2 and Streptococcus suis (S. suis) also reduced the production of NF-κB-directed inflammatory cytokines. To further examine the cytokine profiles and the disease severity by the mutant virus in natural host animals, 6 groups of pigs, 7 animals per group, were used for co-infection with the mutant PRRSV-2 and S. suis. The double-mutant PRRSV-2 was clinically attenuated, and the expressions of proinflammatory cytokines and chemokines were significantly reduced in pigs after bacterial co-infection. Compared to the wild-type PRRSV-2 and S. suis co-infection control, pigs coinfected with the double-mutant PRRSV-2 exhibited milder clinical signs, lower titers and shorter duration of viremia, and lower expression of proinflammatory cytokines. In conclusion, our study demonstrates that genetic modification of the type I IFN suppression and NF-κB activation functions of PRRSV-2 may allow us to design a novel vaccine candidate to alleviate the clinical severity of PRRS-2 and PRDC during bacterial co-infection.
Porcine reproductive and respiratory syndrome virus (PRRSV) is known to suppress the type I interferon (IFNs-α/β) response during infection. PRRSV also activates the NF-κB signaling pathway, leading to the production of proinflammatory cytokines during infection. In swine farms, co-infections of PRRSV and other secondary bacterial pathogens are common and exacerbate the production of proinflammatory cytokines, contributing to the porcine respiratory disease complex (PRDC) which is clinically a severe disease. Previous studies identified the non-structural protein 1β (nsp1β) of PRRSV-2 as an IFN antagonist and the nucleocapsid (N) protein as the NF-κB activator. Further studies showed the leucine at position 126 (L126) of nsp1β as the essential residue for IFN suppression and the region spanning the nuclear localization signal (NLS) of N as the NF-κB activation domain. In the present study, we generated a double-mutant PRRSV-2 that contained the L126A mutation in the nsp1β gene and the NLS mutation (ΔNLS) in the N gene using reverse genetics. The immunological phenotype of this mutant PRRSV-2 was examined in porcine alveolar macrophages (PAMs) in vitro and in young pigs in vivo. In PAMs, the double-mutant virus did not suppress IFN-β expression but decreased the NF-κB-dependent inflammatory cytokine productions compared to those for wild-type PRRSV-2. Co-infection of PAMs with the mutant PRRSV-2 and (. ) also reduced the production of NF-κB-directed inflammatory cytokines. To further examine the cytokine profiles and the disease severity by the mutant virus in natural host animals, 6 groups of pigs, 7 animals per group, were used for co-infection with the mutant PRRSV-2 and . . The double-mutant PRRSV-2 was clinically attenuated, and the expressions of proinflammatory cytokines and chemokines were significantly reduced in pigs after bacterial co-infection. Compared to the wild-type PRRSV-2 and . co-infection control, pigs coinfected with the double-mutant PRRSV-2 exhibited milder clinical signs, lower titers and shorter duration of viremia, and lower expression of proinflammatory cytokines. In conclusion, our study demonstrates that genetic modification of the type I IFN suppression and NF-κB activation functions of PRRSV-2 may allow us to design a novel vaccine candidate to alleviate the clinical severity of PRRS-2 and PRDC during bacterial co-infection.
Porcine reproductive and respiratory syndrome virus (PRRSV) is known to suppress the type I interferon (IFNs-α/β) response during infection. PRRSV also activates the NF-κB signaling pathway, leading to the production of proinflammatory cytokines during infection. In swine farms, co-infections of PRRSV and other secondary bacterial pathogens are common and exacerbate the production of proinflammatory cytokines, contributing to the porcine respiratory disease complex (PRDC) which is clinically a severe disease. Previous studies identified the non-structural protein 1β (nsp1β) of PRRSV-2 as an IFN antagonist and the nucleocapsid (N) protein as the NF-κB activator. Further studies showed the leucine at position 126 (L126) of nsp1β as the essential residue for IFN suppression and the region spanning the nuclear localization signal (NLS) of N as the NF-κB activation domain. In the present study, we generated a double-mutant PRRSV-2 that contained the L126A mutation in the nsp1β gene and the NLS mutation (ΔNLS) in the N gene using reverse genetics. The immunological phenotype of this mutant PRRSV-2 was examined in porcine alveolar macrophages (PAMs) in vitro and in young pigs in vivo. In PAMs, the double-mutant virus did not suppress IFN-β expression but decreased the NF-κB-dependent inflammatory cytokine productions compared to those for wild-type PRRSV-2. Co-infection of PAMs with the mutant PRRSV-2 and Streptococcus suis (S . suis) also reduced the production of NF-κB-directed inflammatory cytokines. To further examine the cytokine profiles and the disease severity by the mutant virus in natural host animals, 6 groups of pigs, 7 animals per group, were used for co-infection with the mutant PRRSV-2 and S . suis . The double-mutant PRRSV-2 was clinically attenuated, and the expressions of proinflammatory cytokines and chemokines were significantly reduced in pigs after bacterial co-infection. Compared to the wild-type PRRSV-2 and S . suis co-infection control, pigs coinfected with the double-mutant PRRSV-2 exhibited milder clinical signs, lower titers and shorter duration of viremia, and lower expression of proinflammatory cytokines. In conclusion, our study demonstrates that genetic modification of the type I IFN suppression and NF-κB activation functions of PRRSV-2 may allow us to design a novel vaccine candidate to alleviate the clinical severity of PRRS-2 and PRDC during bacterial co-infection. Porcine reproductive and respiratory syndrome virus (PRRSV) is a significant swine pathogen worldwide. PRRSV suppresses the type I interferon (IFN) response and activates the NF-κB signaling, leading to the production of proinflammatory cytokines. Co-infection of PRRSV and a secondary pathogen is common in farms and exacerbates the production of proinflammatory cytokines, contributing to the porcine respiratory disease complex (PRDC) which is a clinically severe disease. Here, we generated a double-mutant PRRSV-2 in the nsp1β and N genes by reverse genetics. In cells, the mutant virus did not suppress IFN expression and reduced the NF-κB-mediated inflammatory cytokines compared to wild-type PRRSV-2. Co-infection of macrophages with the mutant virus and Streptococcus suis reduced the production of inflammatory cytokines. The immunological phenotypes of the mutant PRRSV-2 were examined in pigs, 6 groups of pigs, 7 animals per group, after co-infection with S . suis . The double-mutant PRRSV-2 was clinically attenuated, and the expressions of proinflammatory cytokines were significantly reduced in pigs after bacterial co-infection. Our study provides insights that the reprogramming of viral immune antagonism may allow to design of a novel vaccine candidate to alleviate the clinical severity of PRRS and PRDC during co-infection.
Porcine reproductive and respiratory syndrome virus (PRRSV) is known to suppress the type I interferon (IFNs-α/β) response during infection. PRRSV also activates the NF-κB signaling pathway, leading to the production of proinflammatory cytokines during infection. In swine farms, co-infections of PRRSV and other secondary bacterial pathogens are common and exacerbate the production of proinflammatory cytokines, contributing to the porcine respiratory disease complex (PRDC) which is clinically a severe disease. Previous studies identified the non-structural protein 1β (nsp1β) of PRRSV-2 as an IFN antagonist and the nucleocapsid (N) protein as the NF-κB activator. Further studies showed the leucine at position 126 (L126) of nsp1β as the essential residue for IFN suppression and the region spanning the nuclear localization signal (NLS) of N as the NF-κB activation domain. In the present study, we generated a double-mutant PRRSV-2 that contained the L126A mutation in the nsp1β gene and the NLS mutation (ΔNLS) in the N gene using reverse genetics. The immunological phenotype of this mutant PRRSV-2 was examined in porcine alveolar macrophages (PAMs) in vitro and in young pigs in vivo. In PAMs, the double-mutant virus did not suppress IFN-β expression but decreased the NF-κB-dependent inflammatory cytokine productions compared to those for wild-type PRRSV-2. Co-infection of PAMs with the mutant PRRSV-2 and Streptococcus suis (S. suis) also reduced the production of NF-κB-directed inflammatory cytokines. To further examine the cytokine profiles and the disease severity by the mutant virus in natural host animals, 6 groups of pigs, 7 animals per group, were used for co-infection with the mutant PRRSV-2 and S. suis. The double-mutant PRRSV-2 was clinically attenuated, and the expressions of proinflammatory cytokines and chemokines were significantly reduced in pigs after bacterial co-infection. Compared to the wild-type PRRSV-2 and S. suis co-infection control, pigs coinfected with the double-mutant PRRSV-2 exhibited milder clinical signs, lower titers and shorter duration of viremia, and lower expression of proinflammatory cytokines. In conclusion, our study demonstrates that genetic modification of the type I IFN suppression and NF-κB activation functions of PRRSV-2 may allow us to design a novel vaccine candidate to alleviate the clinical severity of PRRS-2 and PRDC during bacterial co-infection.Porcine reproductive and respiratory syndrome virus (PRRSV) is known to suppress the type I interferon (IFNs-α/β) response during infection. PRRSV also activates the NF-κB signaling pathway, leading to the production of proinflammatory cytokines during infection. In swine farms, co-infections of PRRSV and other secondary bacterial pathogens are common and exacerbate the production of proinflammatory cytokines, contributing to the porcine respiratory disease complex (PRDC) which is clinically a severe disease. Previous studies identified the non-structural protein 1β (nsp1β) of PRRSV-2 as an IFN antagonist and the nucleocapsid (N) protein as the NF-κB activator. Further studies showed the leucine at position 126 (L126) of nsp1β as the essential residue for IFN suppression and the region spanning the nuclear localization signal (NLS) of N as the NF-κB activation domain. In the present study, we generated a double-mutant PRRSV-2 that contained the L126A mutation in the nsp1β gene and the NLS mutation (ΔNLS) in the N gene using reverse genetics. The immunological phenotype of this mutant PRRSV-2 was examined in porcine alveolar macrophages (PAMs) in vitro and in young pigs in vivo. In PAMs, the double-mutant virus did not suppress IFN-β expression but decreased the NF-κB-dependent inflammatory cytokine productions compared to those for wild-type PRRSV-2. Co-infection of PAMs with the mutant PRRSV-2 and Streptococcus suis (S. suis) also reduced the production of NF-κB-directed inflammatory cytokines. To further examine the cytokine profiles and the disease severity by the mutant virus in natural host animals, 6 groups of pigs, 7 animals per group, were used for co-infection with the mutant PRRSV-2 and S. suis. The double-mutant PRRSV-2 was clinically attenuated, and the expressions of proinflammatory cytokines and chemokines were significantly reduced in pigs after bacterial co-infection. Compared to the wild-type PRRSV-2 and S. suis co-infection control, pigs coinfected with the double-mutant PRRSV-2 exhibited milder clinical signs, lower titers and shorter duration of viremia, and lower expression of proinflammatory cytokines. In conclusion, our study demonstrates that genetic modification of the type I IFN suppression and NF-κB activation functions of PRRSV-2 may allow us to design a novel vaccine candidate to alleviate the clinical severity of PRRS-2 and PRDC during bacterial co-infection.
Porcine reproductive and respiratory syndrome virus (PRRSV) is known to suppress the type I interferon (IFNs-[alpha]/[beta]) response during infection. PRRSV also activates the NF-[kappa]B signaling pathway, leading to the production of proinflammatory cytokines during infection. In swine farms, co-infections of PRRSV and other secondary bacterial pathogens are common and exacerbate the production of proinflammatory cytokines, contributing to the porcine respiratory disease complex (PRDC) which is clinically a severe disease. Previous studies identified the non-structural protein 1[beta] (nsp1[beta]) of PRRSV-2 as an IFN antagonist and the nucleocapsid (N) protein as the NF-[kappa]B activator. Further studies showed the leucine at position 126 (L126) of nsp1[beta] as the essential residue for IFN suppression and the region spanning the nuclear localization signal (NLS) of N as the NF-[kappa]B activation domain. In the present study, we generated a double-mutant PRRSV-2 that contained the L126A mutation in the nsp1[beta] gene and the NLS mutation ([DELTA]NLS) in the N gene using reverse genetics. The immunological phenotype of this mutant PRRSV-2 was examined in porcine alveolar macrophages (PAMs) in vitro and in young pigs in vivo. In PAMs, the double-mutant virus did not suppress IFN-[beta] expression but decreased the NF-[kappa]B-dependent inflammatory cytokine productions compared to those for wild-type PRRSV-2. Co-infection of PAMs with the mutant PRRSV-2 and Streptococcus suis (S. suis) also reduced the production of NF-[kappa]B-directed inflammatory cytokines. To further examine the cytokine profiles and the disease severity by the mutant virus in natural host animals, 6 groups of pigs, 7 animals per group, were used for co-infection with the mutant PRRSV-2 and S. suis. The double-mutant PRRSV-2 was clinically attenuated, and the expressions of proinflammatory cytokines and chemokines were significantly reduced in pigs after bacterial co-infection. Compared to the wild-type PRRSV-2 and S. suis co-infection control, pigs coinfected with the double-mutant PRRSV-2 exhibited milder clinical signs, lower titers and shorter duration of viremia, and lower expression of proinflammatory cytokines. In conclusion, our study demonstrates that genetic modification of the type I IFN suppression and NF-[kappa]B activation functions of PRRSV-2 may allow us to design a novel vaccine candidate to alleviate the clinical severity of PRRS-2 and PRDC during bacterial co-infection.
Porcine reproductive and respiratory syndrome virus (PRRSV) is known to suppress the type I interferon (IFNs-α/β) response during infection. PRRSV also activates the NF-κB signaling pathway, leading to the production of proinflammatory cytokines during infection. In swine farms, co-infections of PRRSV and other secondary bacterial pathogens are common and exacerbate the production of proinflammatory cytokines, contributing to the porcine respiratory disease complex (PRDC) which is clinically a severe disease. Previous studies identified the non-structural protein 1β (nsp1β) of PRRSV-2 as an IFN antagonist and the nucleocapsid (N) protein as the NF-κB activator. Further studies showed the leucine at position 126 (L126) of nsp1β as the essential residue for IFN suppression and the region spanning the nuclear localization signal (NLS) of N as the NF-κB activation domain. In the present study, we generated a double-mutant PRRSV-2 that contained the L126A mutation in the nsp1β gene and the NLS mutation (ΔNLS) in the N gene using reverse genetics. The immunological phenotype of this mutant PRRSV-2 was examined in porcine alveolar macrophages (PAMs) in vitro and in young pigs in vivo. In PAMs, the double-mutant virus did not suppress IFN-β expression but decreased the NF-κB-dependent inflammatory cytokine productions compared to those for wild-type PRRSV-2. Co-infection of PAMs with the mutant PRRSV-2 and Streptococcus suis (S . suis) also reduced the production of NF-κB-directed inflammatory cytokines. To further examine the cytokine profiles and the disease severity by the mutant virus in natural host animals, 6 groups of pigs, 7 animals per group, were used for co-infection with the mutant PRRSV-2 and S . suis . The double-mutant PRRSV-2 was clinically attenuated, and the expressions of proinflammatory cytokines and chemokines were significantly reduced in pigs after bacterial co-infection. Compared to the wild-type PRRSV-2 and S . suis co-infection control, pigs coinfected with the double-mutant PRRSV-2 exhibited milder clinical signs, lower titers and shorter duration of viremia, and lower expression of proinflammatory cytokines. In conclusion, our study demonstrates that genetic modification of the type I IFN suppression and NF-κB activation functions of PRRSV-2 may allow us to design a novel vaccine candidate to alleviate the clinical severity of PRRS-2 and PRDC during bacterial co-infection.
Audience Academic
Author Su, Chia-Ming
Kim, Jineui
Tang, Junyu
Husmann, Robert
Kim, Jiyoun
Lee, Young-Min
Hung, Yu Fan
Roady, Patrick
Yoo, Dongwan
Zuckermann, Federico A.
AuthorAffiliation 3 Department of Animal, Dairy, and Veterinary Sciences, Utah State University, Logan, Utah, United States of America
2 Department of Veterinary Clinical Medicine, College of Veterinary Medicine, University of Illinois at Urbana-Champaign, Urbana, Illinois, United States of America
Leiden University Medical Center, NETHERLANDS
1 Department of Pathobiology, College of Veterinary Medicine, University of Illinois at Urbana-Champaign, Urbana, Illinois, United States of America
AuthorAffiliation_xml – name: 1 Department of Pathobiology, College of Veterinary Medicine, University of Illinois at Urbana-Champaign, Urbana, Illinois, United States of America
– name: 3 Department of Animal, Dairy, and Veterinary Sciences, Utah State University, Logan, Utah, United States of America
– name: Leiden University Medical Center, NETHERLANDS
– name: 2 Department of Veterinary Clinical Medicine, College of Veterinary Medicine, University of Illinois at Urbana-Champaign, Urbana, Illinois, United States of America
Author_xml – sequence: 1
  givenname: Chia-Ming
  surname: Su
  fullname: Su, Chia-Ming
– sequence: 2
  givenname: Jineui
  surname: Kim
  fullname: Kim, Jineui
– sequence: 3
  givenname: Junyu
  surname: Tang
  fullname: Tang, Junyu
– sequence: 4
  givenname: Yu Fan
  surname: Hung
  fullname: Hung, Yu Fan
– sequence: 5
  givenname: Federico A.
  surname: Zuckermann
  fullname: Zuckermann, Federico A.
– sequence: 6
  givenname: Robert
  surname: Husmann
  fullname: Husmann, Robert
– sequence: 7
  givenname: Patrick
  surname: Roady
  fullname: Roady, Patrick
– sequence: 8
  givenname: Jiyoun
  surname: Kim
  fullname: Kim, Jiyoun
– sequence: 9
  givenname: Young-Min
  surname: Lee
  fullname: Lee, Young-Min
– sequence: 10
  givenname: Dongwan
  orcidid: 0000-0002-6730-9729
  surname: Yoo
  fullname: Yoo, Dongwan
BackLink https://www.ncbi.nlm.nih.gov/pubmed/38547254$$D View this record in MEDLINE/PubMed
BookMark eNqVk9tu1DAQhiNURA_wBggscQMXWew4R27QquJQqQKJw7Xl2JNdl8QOtrN0H5J3Yra7rbpVhUC5SDT-_n_GM5nj5MA6C0nylNEZ4xV7feEmb2U_G0cZZ4yyjGX1g-SIFQVPK17lB7e-D5PjEC4ozRln5aPkkNdFXmVFfpT8nhPVG2uU7Ps1kTGCnWQETbSb2h7SYYrSRuI6MjqvjAXiYfROTyqaFRBpNQbCaLyMzq9JWFvt3QBkZfwU0ozEpYzoBYFYFwkqhxHdVuDhckRhMM5emXtnbNfLYdj6qHV0PzBbIHryxi6IcikCgFlR8MvEJZEkgHJWS8SxBUu3APs4edjJPsCT3fsk-f7-3bfTj-n55w9np_PzVJVNEVNG2wq6GtqKNl0uM1azoqUadMPbkiuqeFHmDeNadi1iXFa8LlUNTaZbyUHzk-T51nfsXRC7SQTBadmwmvOiQuJsS2gnL8TozYB1CieNuAo4vxDSR6N6EDmjWV7ljc5onXcNbVReSgqFVFwVUDD0ervLNrUDaAU2etnvme6fWLMUC7cSjFHKyyZHh5c7B-9-ThCiGExQ0PfSgpuwcFYg1xTVP6A0y4oq4yVF9MUd9P5O7KiFxMviEB3WqDamYl7VNS_rjJZIze6h8NEwGBwzdAbje4JXewJkIlzGhZxCEGdfv_wH-2mffXa72Tddvl4ZBPItoLwLwUN3gzAqNpt53QWx2Uyx20yUvbkjUybKze-MFzX938V_ADyxRag
CitedBy_id crossref_primary_10_1186_s13567_024_01390_y
crossref_primary_10_1016_j_vetmic_2024_110243
crossref_primary_10_1016_j_virol_2025_110484
crossref_primary_10_1016_j_virol_2024_110378
Cites_doi 10.1002/eji.200635993
10.1128/JVI.00177-12
10.1186/1743-422X-7-184
10.1182/blood-2008-11-188458
10.1038/s41598-019-47495-9
10.1016/j.virol.2017.02.004
10.1016/j.vetmic.2017.03.014
10.1371/journal.pone.0016577
10.1099/jgv.0.001632
10.4049/jimmunol.176.6.3315
10.1128/JVI.79.12.7535-7543.2005
10.1128/CMR.00111-17
10.1007/978-1-4615-5331-1_59
10.1371/journal.pone.0040865
10.1016/j.vetmic.2015.08.026
10.1128/JVI.05941-11
10.1016/j.vetimm.2015.07.003
10.1006/meth.2001.1262
10.1053/rvsc.1998.0277
10.4049/jimmunol.174.8.4465
10.1128/iai.00574-21
10.1084/jem.20050821
10.1038/s41598-018-31554-8
10.1128/JVI.01646-08
10.1002/jcla.24881
10.4049/jimmunol.176.8.4682
10.1007/s00281-017-0639-8
10.3390/v4040424
10.3389/fmicb.2023.1159590
10.1354/vp.37-2-143
10.4049/jimmunol.176.8.4525
10.1007/978-0-387-33012-9_25
10.1371/journal.pone.0156019
10.1038/ni978
10.1038/icb.2012.10
10.1016/j.tvjl.2015.10.030
10.1016/j.virusres.2014.11.006
10.1038/cmi.2015.74
10.1016/j.virol.2009.11.033
10.1128/JVI.00655-10
10.1038/s41590-022-01160-y
10.1146/annurev.immunol.16.1.27
10.1016/j.virol.2005.07.034
10.1146/annurev-immunol-032713-120231
10.1089/vim.2010.0051
10.1016/j.virol.2010.08.025
10.4049/jimmunol.178.9.5839
10.1016/S0749-0720(15)30006-2
10.1006/viro.2002.1612
10.1016/j.virusres.2014.09.007
10.1111/tbed.13072
10.1128/JVI.02360-14
10.1371/journal.ppat.1002407
10.1016/j.vetmic.2017.03.035
10.4049/jimmunol.0900592
10.1128/JVI.73.1.270-280.1999
10.1128/CVI.00304-06
10.1093/emboj/cdg267
10.1016/j.virol.2016.03.005
10.1016/S0165-2427(97)00134-7
10.1016/j.virol.2018.01.016
10.1016/j.vetimm.2010.01.002
10.4049/jimmunol.177.3.1746
10.1177/030098589503200606
10.4049/jimmunol.176.4.2074
10.1186/1743-422X-9-83
10.1128/JVI.01396-14
10.1016/j.virol.2010.03.039
10.1099/vir.0.014001-0
10.3201/eid1902.120470
10.1016/j.virol.2005.11.005
10.1016/j.molimm.2010.10.022
10.1016/j.virusres.2008.02.012
10.4049/jimmunol.1001140
10.1007/s007050070022
10.1093/oxfordjournals.aje.a118408
10.1007/s12016-021-08908-8
10.1016/S0968-0004(99)01530-3
ContentType Journal Article
Copyright Copyright: © 2024 Su et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
COPYRIGHT 2024 Public Library of Science
2024 Su et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2024 Su et al 2024 Su et al
2024 Su et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: Copyright: © 2024 Su et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
– notice: COPYRIGHT 2024 Public Library of Science
– notice: 2024 Su et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2024 Su et al 2024 Su et al
– notice: 2024 Su et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID AAYXX
CITATION
NPM
ISN
ISR
3V.
7QL
7U9
7X7
7XB
88E
8FE
8FH
8FI
8FJ
8FK
ABUWG
AEUYN
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
C1K
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
H94
HCIFZ
K9.
LK8
M0S
M1P
M7P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
7X8
7S9
L.6
5PM
DOA
DOI 10.1371/journal.ppat.1012128
DatabaseName CrossRef
PubMed
Gale In Context: Canada
Gale In Context: Science
ProQuest Central (Corporate)
Bacteriology Abstracts (Microbiology B)
Virology and AIDS Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni Edition)
ProQuest One Sustainability
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
Environmental Sciences and Pollution Management
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
AIDS and Cancer Research Abstracts
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
ProQuest Biological Science Collection
Health & Medical Collection (Alumni Edition)
Medical Database
Biological Science Database
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
PubMed
Publicly Available Content Database
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
Environmental Sciences and Pollution Management
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Bacteriology Abstracts (Microbiology B)
Health & Medical Research Collection
Biological Science Collection
AIDS and Cancer Research Abstracts
ProQuest Central (New)
ProQuest Medical Library (Alumni)
Virology and AIDS Abstracts
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
DatabaseTitleList
AGRICOLA


MEDLINE - Academic

Publicly Available Content Database
PubMed
CrossRef
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
DocumentTitleAlternate Type I interferon suppression-negative and NF-κB activation-negative PRRSV
EISSN 1553-7374
ExternalDocumentID 3069183357
oai_doaj_org_article_41024749d2084f909c46a0e5ac3c5e51
PMC11003694
A788368206
38547254
10_1371_journal_ppat_1012128
Genre Journal Article
GeographicLocations United States
GeographicLocations_xml – name: United States
GrantInformation_xml – fundername: ;
  grantid: 2018-67016-28296
– fundername: ;
  grantid: ILLU-888-944
– fundername: ;
  grantid: 2018-67015-28287
– fundername: ;
  grantid: 2023-67015-39710
GroupedDBID ---
123
29O
2WC
53G
5VS
7X7
88E
8FE
8FH
8FI
8FJ
AAFWJ
AAUCC
AAWOE
AAYXX
ABDBF
ABUWG
ACGFO
ACIHN
ACPRK
ACUHS
ADBBV
AEAQA
AENEX
AEUYN
AFKRA
AFPKN
AFRAH
AHMBA
ALMA_UNASSIGNED_HOLDINGS
AOIJS
B0M
BAWUL
BBNVY
BCNDV
BENPR
BHPHI
BPHCQ
BVXVI
BWKFM
CCPQU
CITATION
CS3
DIK
DU5
E3Z
EAP
EAS
EBD
EMK
EMOBN
ESX
F5P
FPL
FYUFA
GROUPED_DOAJ
GX1
HCIFZ
HMCUK
HYE
IAO
IHR
INH
INR
ISN
ISR
ITC
KQ8
LK8
M1P
M48
M7P
MM.
O5R
O5S
OK1
OVT
P2P
PGMZT
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
PV9
QF4
QN7
RNS
RPM
RZL
SV3
TR2
TUS
UKHRP
WOW
~8M
NPM
PJZUB
PPXIY
PQGLB
PMFND
3V.
7QL
7U9
7XB
8FK
AZQEC
C1K
DWQXO
GNUQQ
H94
K9.
PKEHL
PQEST
PQUKI
7X8
7S9
L.6
5PM
PUEGO
ID FETCH-LOGICAL-c695t-10b7ef8eb709f4a21815b0ded93b63c0c3564913dafbf8e3a7386c8e92dba3ed3
IEDL.DBID M48
ISSN 1553-7374
1553-7366
IngestDate Tue Aug 12 00:50:56 EDT 2025
Wed Aug 27 01:23:27 EDT 2025
Thu Aug 21 18:34:05 EDT 2025
Thu Jul 10 19:22:53 EDT 2025
Thu Jul 10 20:00:03 EDT 2025
Fri Jul 25 12:09:59 EDT 2025
Tue Jun 17 22:14:05 EDT 2025
Tue Jun 10 21:11:13 EDT 2025
Fri Jun 27 06:01:02 EDT 2025
Fri Jun 27 05:49:28 EDT 2025
Mon Jul 21 05:53:39 EDT 2025
Thu Apr 24 22:50:23 EDT 2025
Tue Jul 01 01:05:40 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Language English
License Copyright: © 2024 Su et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Creative Commons Attribution License
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c695t-10b7ef8eb709f4a21815b0ded93b63c0c3564913dafbf8e3a7386c8e92dba3ed3
Notes new_version
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
Current address: Department of Biochemistry and Cell Biology, School of Medicine, Boston University, Boston, Massachusetts, United States of America
Current address: Department of Microbiology, Institute for Viral Diseases, Vaccine Innovation Center, College of Medicine, Korea University, Seoul, Korea
The authors have declared that no competing interests exist.
ORCID 0000-0002-6730-9729
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.1371/journal.ppat.1012128
PMID 38547254
PQID 3069183357
PQPubID 1436335
PageCount e1012128
ParticipantIDs plos_journals_3069183357
doaj_primary_oai_doaj_org_article_41024749d2084f909c46a0e5ac3c5e51
pubmedcentral_primary_oai_pubmedcentral_nih_gov_11003694
proquest_miscellaneous_3153699574
proquest_miscellaneous_3022572360
proquest_journals_3069183357
gale_infotracmisc_A788368206
gale_infotracacademiconefile_A788368206
gale_incontextgauss_ISR_A788368206
gale_incontextgauss_ISN_A788368206
pubmed_primary_38547254
crossref_primary_10_1371_journal_ppat_1012128
crossref_citationtrail_10_1371_journal_ppat_1012128
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20240328
PublicationDateYYYYMMDD 2024-03-28
PublicationDate_xml – month: 3
  year: 2024
  text: 20240328
  day: 28
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: San Francisco
– name: San Francisco, CA USA
PublicationTitle PLoS pathogens
PublicationTitleAlternate PLoS Pathog
PublicationYear 2024
Publisher Public Library of Science
Public Library of Science (PLoS)
Publisher_xml – name: Public Library of Science
– name: Public Library of Science (PLoS)
References GA Kolumam (ppat.1012128.ref008) 2005; 202
P Bach (ppat.1012128.ref017) 2007; 178
E Albina (ppat.1012128.ref021) 1998; 61
LJ Thompson (ppat.1012128.ref016) 2006; 177
C Song (ppat.1012128.ref031) 2010; 407
WE Purtha (ppat.1012128.ref019) 2008; 82
FA Zuckermann (ppat.1012128.ref080) 2022; 90
S Wootton (ppat.1012128.ref026) 2000; 145
JC Miguel (ppat.1012128.ref072) 2010; 135
KS Makarova (ppat.1012128.ref046) 2000; 25
Y Fang (ppat.1012128.ref036) 2012; 9
K Jung (ppat.1012128.ref058) 2009; 90
J Li (ppat.1012128.ref044) 2017; 204
NT Hoa (ppat.1012128.ref050) 2013; 19
CL Loving (ppat.1012128.ref068) 2015; 167
DJ Thomas (ppat.1012128.ref082) 2011; 6
H Ke (ppat.1012128.ref062) 2018; 517
SM Lee (ppat.1012128.ref074) 2005; 342
LJ REED (ppat.1012128.ref083) 1938; 27
OJ Lopez (ppat.1012128.ref066) 2007; 14
GJ Renukaradhya (ppat.1012128.ref059) 2010; 23
Y Wang (ppat.1012128.ref053) 2011; 48
A Le Bon (ppat.1012128.ref010) 2003; 4
J Li (ppat.1012128.ref060) 2019; 66
HJ Ramos (ppat.1012128.ref015) 2009; 113
C Havenar-Daughton (ppat.1012128.ref002) 2006; 176
H Ke (ppat.1012128.ref027) 2017; 209
CJ Nelsen (ppat.1012128.ref025) 1999; 73
SJ Keppler (ppat.1012128.ref007) 2012; 7
A Le Bon (ppat.1012128.ref009) 2006; 176
N Kumar (ppat.1012128.ref069) 2018; 31
HD Marshall (ppat.1012128.ref006) 2010; 185
WP Arend (ppat.1012128.ref056) 1998; 16
S Tahtinen (ppat.1012128.ref057) 2022; 23
KJ Livak (ppat.1012128.ref079) 2001; 25
O Kim (ppat.1012128.ref047) 2010; 402
WM Schneider (ppat.1012128.ref001) 2014; 32
M Han (ppat.1012128.ref029) 2014; 194
M Han (ppat.1012128.ref033) 2017; 505
G Auray (ppat.1012128.ref043) 2016; 11
M Xu (ppat.1012128.ref061) 2010; 7
S Qin (ppat.1012128.ref039) 2018; 8
SL Brockmeier (ppat.1012128.ref049) 2002
WY Chen (ppat.1012128.ref071) 2018; 92
D Patel (ppat.1012128.ref030) 2010; 84
W Buddaert (ppat.1012128.ref022) 1998; 440
Y Fu (ppat.1012128.ref073) 2012; 86
S Wang (ppat.1012128.ref051) 2023; 14
FA Osorio (ppat.1012128.ref067) 2002; 302
RN Jennings (ppat.1012128.ref014) 2014; 88
L Kavanová (ppat.1012128.ref077) 2015; 180
HM Elbadawy (ppat.1012128.ref055) 2023; 37
C. Chae (ppat.1012128.ref040) 2016; 212
BG Chousterman (ppat.1012128.ref041) 2017; 39
H Ke (ppat.1012128.ref032) 2019; 93
Y Sun (ppat.1012128.ref035) 2012; 4
A Le Bon (ppat.1012128.ref003) 2006; 176
K Fink (ppat.1012128.ref018) 2006; 36
JM Curtsinger (ppat.1012128.ref005) 2005; 174
N Sun (ppat.1012128.ref045) 2016; 6
K Kiefer (ppat.1012128.ref020) 2012; 90
C Huang (ppat.1012128.ref034) 2014; 88
EL Thacker (ppat.1012128.ref048) 2001; 17
B Li (ppat.1012128.ref078) 2015; 196
K Van Reeth (ppat.1012128.ref023) 1999; 67
C Lee (ppat.1012128.ref052) 2006; 346
FD Segundo (ppat.1012128.ref064) 2012; 86
MA Brinton (ppat.1012128.ref024) 2021; 102
C Lee (ppat.1012128.ref075) 2006; 581
R Thanawongnuwech (ppat.1012128.ref038) 2000; 37
R Qin (ppat.1012128.ref054) 2023; 64
A Solórzano (ppat.1012128.ref065) 2005; 79
MG Santoro (ppat.1012128.ref070) 2003; 22
Y Pei (ppat.1012128.ref076) 2008; 135
SL Urban (ppat.1012128.ref011) 2016; 493
P Agarwal (ppat.1012128.ref013) 2009; 183
Y Li (ppat.1012128.ref063) 2014; 111
P Aichele (ppat.1012128.ref004) 2006; 176
Z Chen (ppat.1012128.ref028) 2010; 398
Q Liu (ppat.1012128.ref042) 2016; 13
AK Pinto (ppat.1012128.ref012) 2011; 7
H Ke (ppat.1012128.ref037) 2019; 9
PG Halbur (ppat.1012128.ref081) 1995; 32
References_xml – volume: 36
  start-page: 2094
  issue: 8
  year: 2006
  ident: ppat.1012128.ref018
  article-title: Early type I interferon-mediated signals on B cells specifically enhance antiviral humoral responses
  publication-title: Eur J Immunol
  doi: 10.1002/eji.200635993
– volume: 86
  start-page: 7625
  issue: 14
  year: 2012
  ident: ppat.1012128.ref073
  article-title: Porcine reproductive and respiratory syndrome virus induces interleukin-15 through the NF-κB signaling pathway
  publication-title: J Virol
  doi: 10.1128/JVI.00177-12
– volume: 7
  start-page: 184
  year: 2010
  ident: ppat.1012128.ref061
  article-title: Secondary infection with Streptococcus suis serotype 7 increases the virulence of highly pathogenic porcine reproductive and respiratory syndrome virus in pigs.
  publication-title: Virol J.
  doi: 10.1186/1743-422X-7-184
– volume: 113
  start-page: 5516
  issue: 22
  year: 2009
  ident: ppat.1012128.ref015
  article-title: Reciprocal responsiveness to interleukin-12 and interferon-alpha specifies human CD8+ effector versus central memory T-cell fates
  publication-title: Blood
  doi: 10.1182/blood-2008-11-188458
– volume: 9
  start-page: 11042
  issue: 1
  year: 2019
  ident: ppat.1012128.ref037
  article-title: Interaction of PIAS1 with PRRS virus nucleocapsid protein mediates NF-κB activation and triggers proinflammatory mediators during viral infection.
  publication-title: Sci Rep.
  doi: 10.1038/s41598-019-47495-9
– volume: 505
  start-page: 42
  year: 2017
  ident: ppat.1012128.ref033
  article-title: Nuclear imprisonment of host cellular mRNA by nsp1β protein of porcine reproductive and respiratory syndrome virus
  publication-title: Virology
  doi: 10.1016/j.virol.2017.02.004
– volume: 209
  start-page: 75
  year: 2017
  ident: ppat.1012128.ref027
  article-title: The viral innate immune antagonism and an alternative vaccine design for PRRS virus
  publication-title: Vet Microbiol
  doi: 10.1016/j.vetmic.2017.03.014
– volume: 6
  start-page: e16577
  issue: 2
  year: 2011
  ident: ppat.1012128.ref082
  article-title: Lactobacillus rhamnosus HN001 attenuates allergy development in a pig model
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0016577
– volume: 102
  issue: 8
  year: 2021
  ident: ppat.1012128.ref024
  article-title: ICTV Virus Taxonomy Profile: Arteriviridae 2021
  publication-title: J Gen Virol
  doi: 10.1099/jgv.0.001632
– volume: 176
  start-page: 3315
  issue: 6
  year: 2006
  ident: ppat.1012128.ref002
  article-title: Cutting Edge: The direct action of type I IFN on CD4 T cells is critical for sustaining clonal expansion in response to a viral but not a bacterial infection
  publication-title: J Immunol
  doi: 10.4049/jimmunol.176.6.3315
– volume: 79
  start-page: 7535
  issue: 12
  year: 2005
  ident: ppat.1012128.ref065
  article-title: Mutations in the NS1 protein of swine influenza virus impair anti-interferon activity and confer attenuation in pigs
  publication-title: J Virol
  doi: 10.1128/JVI.79.12.7535-7543.2005
– volume: 31
  issue: 4
  year: 2018
  ident: ppat.1012128.ref069
  article-title: Virological and Immunological Outcomes of Coinfections.
  publication-title: Clin Microbiol Rev
  doi: 10.1128/CMR.00111-17
– volume: 440
  start-page: 461
  year: 1998
  ident: ppat.1012128.ref022
  article-title: In vivo and in vitro interferon (IFN) studies with the porcine reproductive and respiratory syndrome virus (PRRSV).
  publication-title: Adv Exp Med Biol
  doi: 10.1007/978-1-4615-5331-1_59
– volume: 7
  start-page: e40865
  issue: 7
  year: 2012
  ident: ppat.1012128.ref007
  article-title: Signal 3 cytokines as modulators of primary immune responses during infections: the interplay of type I IFN and IL-12 in CD8 T cell responses
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0040865
– volume: 180
  start-page: 28
  issue: 1–2
  year: 2015
  ident: ppat.1012128.ref077
  article-title: Immune response of porcine alveolar macrophages to a concurrent infection with porcine reproductive and respiratory syndrome virus and Haemophilus parasuis in vitro
  publication-title: Vet Microbiol
  doi: 10.1016/j.vetmic.2015.08.026
– volume: 86
  start-page: 1316
  issue: 3
  year: 2012
  ident: ppat.1012128.ref064
  article-title: Inoculation of swine with foot-and-mouth disease SAP-mutant virus induces early protection against disease
  publication-title: J Virol
  doi: 10.1128/JVI.05941-11
– volume: 167
  start-page: 1
  issue: 1–2
  year: 2015
  ident: ppat.1012128.ref068
  article-title: Innate and adaptive immunity against Porcine Reproductive and Respiratory Syndrome Virus
  publication-title: Vet Immunol Immunopathol
  doi: 10.1016/j.vetimm.2015.07.003
– volume: 25
  start-page: 402
  issue: 4
  year: 2001
  ident: ppat.1012128.ref079
  article-title: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.
  publication-title: Methods
  doi: 10.1006/meth.2001.1262
– volume: 67
  start-page: 47
  issue: 1
  year: 1999
  ident: ppat.1012128.ref023
  article-title: Differential production of proinflammatory cytokines in the pig lung during different respiratory virus infections: correlations with pathogenicity
  publication-title: Res Vet Sci
  doi: 10.1053/rvsc.1998.0277
– volume: 174
  start-page: 4465
  issue: 8
  year: 2005
  ident: ppat.1012128.ref005
  article-title: Type I IFNs provide a third signal to CD8 T cells to stimulate clonal expansion and differentiation
  publication-title: J Immunol
  doi: 10.4049/jimmunol.174.8.4465
– volume: 90
  start-page: e0057421
  issue: 4
  year: 2022
  ident: ppat.1012128.ref080
  article-title: Bacillus-Based Direct-Fed Microbial Reduces the Pathogenic Synergy of a Coinfection with Salmonella enterica Serovar Choleraesuis and Porcine Reproductive and Respiratory Syndrome Virus
  publication-title: Infect Immun
  doi: 10.1128/iai.00574-21
– volume: 202
  start-page: 637
  issue: 5
  year: 2005
  ident: ppat.1012128.ref008
  article-title: Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection
  publication-title: J Exp Med
  doi: 10.1084/jem.20050821
– volume: 8
  start-page: 13341
  issue: 1
  year: 2018
  ident: ppat.1012128.ref039
  article-title: Viral communities associated with porcine respiratory disease complex in intensive commercial farms in Sichuan province, China.
  publication-title: Sci Rep
  doi: 10.1038/s41598-018-31554-8
– volume: 82
  start-page: 10964
  issue: 22
  year: 2008
  ident: ppat.1012128.ref019
  article-title: Early B-cell activation after West Nile virus infection requires alpha/beta interferon but not antigen receptor signaling
  publication-title: J Virol
  doi: 10.1128/JVI.01646-08
– volume: 37
  start-page: e24881
  issue: 7
  year: 2023
  ident: ppat.1012128.ref055
  article-title: IL-6 at the center of cytokine storm: Circulating inflammation mediators as biomarkers in hospitalized COVID-19 patients.
  publication-title: J Clin Lab Anal.
  doi: 10.1002/jcla.24881
– volume: 176
  start-page: 4682
  issue: 8
  year: 2006
  ident: ppat.1012128.ref009
  article-title: Direct stimulation of T cells by type I IFN enhances the CD8+ T cell response during cross-priming
  publication-title: J Immunol
  doi: 10.4049/jimmunol.176.8.4682
– volume: 39
  start-page: 517
  issue: 5
  year: 2017
  ident: ppat.1012128.ref041
  article-title: Cytokine storm and sepsis disease pathogenesis
  publication-title: Semin Immunopathol
  doi: 10.1007/s00281-017-0639-8
– volume: 4
  start-page: 424
  issue: 4
  year: 2012
  ident: ppat.1012128.ref035
  article-title: Interplay between interferon-mediated innate immunity and porcine reproductive and respiratory syndrome virus
  publication-title: Viruses
  doi: 10.3390/v4040424
– volume: 14
  start-page: 1159590
  year: 2023
  ident: ppat.1012128.ref051
  article-title: Streptococcus suis contributes to inguinal lymph node lesions in piglets after highly pathogenic porcine reproductive and respiratory syndrome virus infection.
  publication-title: Front Microbiol.
  doi: 10.3389/fmicb.2023.1159590
– volume: 92
  issue: 2
  year: 2018
  ident: ppat.1012128.ref071
  article-title: Genotype 2 Strains of Porcine Reproductive and Respiratory Syndrome Virus Dysregulate Alveolar Macrophage Cytokine Production via the Unfolded Protein Response
  publication-title: J Virol
– volume: 37
  start-page: 143
  issue: 2
  year: 2000
  ident: ppat.1012128.ref038
  article-title: Pathogenesis of porcine reproductive and respiratory syndrome virus-induced increase in susceptibility to Streptococcus suis infection
  publication-title: Vet Pathol
  doi: 10.1354/vp.37-2-143
– volume: 176
  start-page: 4525
  issue: 8
  year: 2006
  ident: ppat.1012128.ref004
  article-title: CD8 T cells specific for lymphocytic choriomeningitis virus require type I IFN receptor for clonal expansion
  publication-title: J Immunol
  doi: 10.4049/jimmunol.176.8.4525
– volume: 581
  start-page: 145
  year: 2006
  ident: ppat.1012128.ref075
  article-title: The nuclear localization signal of the PRRS virus nucleocapsid protein viral replication in vitro and antibody response in vivo
  publication-title: Adv Exp Med Biol
  doi: 10.1007/978-0-387-33012-9_25
– volume: 11
  start-page: e0156019
  issue: 5
  year: 2016
  ident: ppat.1012128.ref043
  article-title: Transcriptional Analysis of PRRSV-Infected Porcine Dendritic Cell Response to Streptococcus suis Infection Reveals Up-Regulation of Inflammatory-Related Genes Expression.
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0156019
– volume: 4
  start-page: 1009
  issue: 10
  year: 2003
  ident: ppat.1012128.ref010
  article-title: Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon
  publication-title: Nat Immunol
  doi: 10.1038/ni978
– volume: 90
  start-page: 498
  issue: 5
  year: 2012
  ident: ppat.1012128.ref020
  article-title: Role of type I interferons in the activation of autoreactive B cells
  publication-title: Immunol Cell Biol
  doi: 10.1038/icb.2012.10
– volume: 212
  start-page: 1
  year: 2016
  ident: ppat.1012128.ref040
  article-title: Porcine respiratory disease complex: Interaction of vaccination and porcine circovirus type 2, porcine reproductive and respiratory syndrome virus, and Mycoplasma hyopneumoniae.
  publication-title: Vet J.
  doi: 10.1016/j.tvjl.2015.10.030
– volume: 196
  start-page: 60
  year: 2015
  ident: ppat.1012128.ref078
  article-title: Transcription analysis on response of porcine alveolar macrophages to co-infection of the highly pathogenic porcine reproductive and respiratory syndrome virus and Mycoplasma hyopneumoniae
  publication-title: Virus Res
  doi: 10.1016/j.virusres.2014.11.006
– volume: 13
  start-page: 3
  issue: 1
  year: 2016
  ident: ppat.1012128.ref042
  article-title: The cytokine storm of severe influenza and development of immunomodulatory therapy
  publication-title: Cell Mol Immunol
  doi: 10.1038/cmi.2015.74
– volume: 398
  start-page: 87
  issue: 1
  year: 2010
  ident: ppat.1012128.ref028
  article-title: Identification of two auto-cleavage products of nonstructural protein 1 (nsp1) in porcine reproductive and respiratory syndrome virus infected cells: nsp1 function as interferon antagonist.
  publication-title: Virology
  doi: 10.1016/j.virol.2009.11.033
– volume: 84
  start-page: 11045
  issue: 21
  year: 2010
  ident: ppat.1012128.ref030
  article-title: Porcine reproductive and respiratory syndrome virus inhibits type I interferon signaling by blocking STAT1/STAT2 nuclear translocation
  publication-title: J Virol
  doi: 10.1128/JVI.00655-10
– volume: 23
  start-page: 532
  issue: 4
  year: 2022
  ident: ppat.1012128.ref057
  article-title: IL-1 and IL-1ra are key regulators of the inflammatory response to RNA vaccines
  publication-title: Nat Immunol
  doi: 10.1038/s41590-022-01160-y
– volume: 16
  start-page: 27
  year: 1998
  ident: ppat.1012128.ref056
  article-title: Interleukin-1 receptor antagonist: role in biology
  publication-title: Annu Rev Immunol
  doi: 10.1146/annurev.immunol.16.1.27
– volume: 342
  start-page: 47
  issue: 1
  year: 2005
  ident: ppat.1012128.ref074
  article-title: Porcine arterivirus activates the NF-kappaB pathway through IkappaB degradation
  publication-title: Virology
  doi: 10.1016/j.virol.2005.07.034
– volume: 32
  start-page: 513
  year: 2014
  ident: ppat.1012128.ref001
  article-title: Interferon-stimulated genes: a complex web of host defenses
  publication-title: Annu Rev Immunol
  doi: 10.1146/annurev-immunol-032713-120231
– volume: 23
  start-page: 457
  issue: 5
  year: 2010
  ident: ppat.1012128.ref059
  article-title: Porcine reproductive and respiratory syndrome virus-induced immunosuppression exacerbates the inflammatory response to porcine respiratory coronavirus in pigs
  publication-title: Viral Immunol
  doi: 10.1089/vim.2010.0051
– volume: 407
  start-page: 268
  issue: 2
  year: 2010
  ident: ppat.1012128.ref031
  article-title: Nonstructural protein 1α subunit-based inhibition of NF-κB activation and suppression of interferon-β production by porcine reproductive and respiratory syndrome virus
  publication-title: Virology
  doi: 10.1016/j.virol.2010.08.025
– volume: 178
  start-page: 5839
  issue: 9
  year: 2007
  ident: ppat.1012128.ref017
  article-title: Vesicular stomatitis virus glycoprotein displaying retrovirus-like particles induce a type I IFN receptor-dependent switch to neutralizing IgG antibodies
  publication-title: J Immunol
  doi: 10.4049/jimmunol.178.9.5839
– volume: 17
  start-page: 551
  issue: 3
  year: 2001
  ident: ppat.1012128.ref048
  article-title: Immunology of the porcine respiratory disease complex
  publication-title: Vet Clin North Am Food Anim Pract
  doi: 10.1016/S0749-0720(15)30006-2
– volume: 302
  start-page: 9
  issue: 1
  year: 2002
  ident: ppat.1012128.ref067
  article-title: Passive transfer of virus-specific antibodies confers protection against reproductive failure induced by a virulent strain of porcine reproductive and respiratory syndrome virus and establishes sterilizing immunity
  publication-title: Virology
  doi: 10.1006/viro.2002.1612
– volume: 194
  start-page: 100
  year: 2014
  ident: ppat.1012128.ref029
  article-title: Modulation of innate immune signaling by nonstructural protein 1 (nsp1) in the family Arteriviridae.
  publication-title: Virus Res
  doi: 10.1016/j.virusres.2014.09.007
– volume: 66
  start-page: 729
  issue: 2
  year: 2019
  ident: ppat.1012128.ref060
  article-title: Porcine reproductive and respiratory syndrome virus NADC30-like strain accelerates Streptococcus suis serotype 2 infection in vivo and in vitro
  publication-title: Transbound Emerg Dis
  doi: 10.1111/tbed.13072
– volume: 88
  start-page: 14040
  issue: 24
  year: 2014
  ident: ppat.1012128.ref014
  article-title: Type I interferon signaling enhances CD8+ T cell effector function and differentiation during murine gammaherpesvirus 68 infection
  publication-title: J Virol
  doi: 10.1128/JVI.02360-14
– volume: 7
  start-page: e1002407
  issue: 12
  year: 2011
  ident: ppat.1012128.ref012
  article-title: A temporal role of type I interferon signaling in CD8+ T cell maturation during acute West Nile virus infection
  publication-title: PLoS Pathog
  doi: 10.1371/journal.ppat.1002407
– volume: 204
  start-page: 35
  year: 2017
  ident: ppat.1012128.ref044
  article-title: Secondary Haemophilus parasuis infection enhances highly pathogenic porcine reproductive and respiratory syndrome virus (HP-PRRSV) infection-mediated inflammatory responses.
  publication-title: Vet Microbiol
  doi: 10.1016/j.vetmic.2017.03.035
– volume: 183
  start-page: 1695
  issue: 3
  year: 2009
  ident: ppat.1012128.ref013
  article-title: Gene regulation and chromatin remodeling by IL-12 and type I IFN in programming for CD8 T cell effector function and memory
  publication-title: J Immunol
  doi: 10.4049/jimmunol.0900592
– volume: 111
  start-page: E2172
  issue: 21
  year: 2014
  ident: ppat.1012128.ref063
  article-title: Transactivation of programmed ribosomal frameshifting by a viral protein
  publication-title: Proc Natl Acad Sci U S A
– volume: 73
  start-page: 270
  issue: 1
  year: 1999
  ident: ppat.1012128.ref025
  article-title: Porcine reproductive and respiratory syndrome virus comparison: divergent evolution on two continents
  publication-title: J Virol
  doi: 10.1128/JVI.73.1.270-280.1999
– volume: 14
  start-page: 269
  issue: 3
  year: 2007
  ident: ppat.1012128.ref066
  article-title: Protection against porcine reproductive and respiratory syndrome virus (PRRSV) infection through passive transfer of PRRSV-neutralizing antibodies is dose dependent.
  publication-title: Clin Vaccine Immunol
  doi: 10.1128/CVI.00304-06
– volume: 22
  start-page: 2552
  issue: 11
  year: 2003
  ident: ppat.1012128.ref070
  article-title: NF-kappaB and virus infection: who controls whom
  publication-title: Embo j
  doi: 10.1093/emboj/cdg267
– volume: 493
  start-page: 52
  year: 2016
  ident: ppat.1012128.ref011
  article-title: Type 1 interferon licenses naïve CD8 T cells to mediate anti-viral cytotoxicity
  publication-title: Virology
  doi: 10.1016/j.virol.2016.03.005
– volume: 61
  start-page: 49
  issue: 1
  year: 1998
  ident: ppat.1012128.ref021
  article-title: Immune responses in pigs infected with porcine reproductive and respiratory syndrome virus (PRRSV).
  publication-title: Vet Immunol Immunopathol
  doi: 10.1016/S0165-2427(97)00134-7
– volume: 517
  start-page: 177
  year: 2018
  ident: ppat.1012128.ref062
  article-title: Type I interferon suppression-negative and host mRNA nuclear retention-negative mutation in nsp1β confers attenuation of porcine reproductive and respiratory syndrome virus in pigs
  publication-title: Virology
  doi: 10.1016/j.virol.2018.01.016
– volume: 135
  start-page: 314
  issue: 3–4
  year: 2010
  ident: ppat.1012128.ref072
  article-title: Expression of inflammatory cytokines and Toll-like receptors in the brain and respiratory tract of pigs infected with porcine reproductive and respiratory syndrome virus
  publication-title: Vet Immunol Immunopathol
  doi: 10.1016/j.vetimm.2010.01.002
– volume: 177
  start-page: 1746
  issue: 3
  year: 2006
  ident: ppat.1012128.ref016
  article-title: Innate inflammatory signals induced by various pathogens differentially dictate the IFN-I dependence of CD8 T cells for clonal expansion and memory formation
  publication-title: J Immunol
  doi: 10.4049/jimmunol.177.3.1746
– volume: 32
  start-page: 648
  issue: 6
  year: 1995
  ident: ppat.1012128.ref081
  article-title: Comparison of the pathogenicity of two US porcine reproductive and respiratory syndrome virus isolates with that of the Lelystad virus
  publication-title: Vet Pathol
  doi: 10.1177/030098589503200606
– volume: 176
  start-page: 2074
  issue: 4
  year: 2006
  ident: ppat.1012128.ref003
  article-title: Cutting edge: enhancement of antibody responses through direct stimulation of B and T cells by type I IFN
  publication-title: J Immunol
  doi: 10.4049/jimmunol.176.4.2074
– volume: 9
  start-page: 83
  year: 2012
  ident: ppat.1012128.ref036
  article-title: Porcine reproductive and respiratory syndrome virus nonstructural protein 2 contributes to NF-κB activation.
  publication-title: Virol J.
  doi: 10.1186/1743-422X-9-83
– volume: 88
  start-page: 10934
  issue: 18
  year: 2014
  ident: ppat.1012128.ref034
  article-title: Porcine reproductive and respiratory syndrome virus nonstructural protein 4 antagonizes beta interferon expression by targeting the NF-κB essential modulator
  publication-title: J Virol
  doi: 10.1128/JVI.01396-14
– volume: 402
  start-page: 315
  issue: 2
  year: 2010
  ident: ppat.1012128.ref047
  article-title: Modulation of type I interferon induction by porcine reproductive and respiratory syndrome virus and degradation of CREB-binding protein by non-structural protein 1 in MARC-145 and HeLa cells
  publication-title: Virology
  doi: 10.1016/j.virol.2010.03.039
– volume: 6
  start-page: 24401
  year: 2016
  ident: ppat.1012128.ref045
  article-title: Matrine displayed antiviral activity in porcine alveolar macrophages co-infected by porcine reproductive and respiratory syndrome virus and porcine circovirus type 2.
  publication-title: Sci Rep.PubMed Central PMCID
– volume: 90
  start-page: 2713
  issue: Pt 11
  year: 2009
  ident: ppat.1012128.ref058
  article-title: Porcine reproductive and respiratory syndrome virus modifies innate immunity and alters disease outcome in pigs subsequently infected with porcine respiratory coronavirus: implications for respiratory viral co-infections
  publication-title: J Gen Virol
  doi: 10.1099/vir.0.014001-0
– volume: 93
  issue: 14
  year: 2019
  ident: ppat.1012128.ref032
  article-title: Porcine Reproductive and Respiratory Syndrome Virus Nonstructural Protein 1 Beta Interacts with Nucleoporin 62 To Promote Viral Replication and Immune Evasion
  publication-title: J Virol
– volume: 19
  start-page: 331
  issue: 2
  year: 2013
  ident: ppat.1012128.ref050
  article-title: Streptococcus suis and porcine reproductive and respiratory syndrome, Vietnam
  publication-title: Emerg Infect Dis
  doi: 10.3201/eid1902.120470
– volume: 346
  start-page: 238
  issue: 1
  year: 2006
  ident: ppat.1012128.ref052
  article-title: Mutations within the nuclear localization signal of the porcine reproductive and respiratory syndrome virus nucleocapsid protein attenuate virus replication
  publication-title: Virology
  doi: 10.1016/j.virol.2005.11.005
– start-page: 231
  year: 2002
  ident: ppat.1012128.ref049
  article-title: Porcine Respiratory Disease Complex.
  publication-title: Polymicrobial Diseases
– volume: 48
  start-page: 586
  issue: 4
  year: 2011
  ident: ppat.1012128.ref053
  article-title: Porcine reproductive and respiratory syndrome virus (PRRSV) infection activates chemokine RANTES in MARC-145 cells.
  publication-title: Mol Immunol
  doi: 10.1016/j.molimm.2010.10.022
– volume: 135
  start-page: 107
  issue: 1
  year: 2008
  ident: ppat.1012128.ref076
  article-title: Functional mapping of the porcine reproductive and respiratory syndrome virus capsid protein nuclear localization signal and its pathogenic association
  publication-title: Virus Res
  doi: 10.1016/j.virusres.2008.02.012
– volume: 185
  start-page: 1419
  issue: 3
  year: 2010
  ident: ppat.1012128.ref006
  article-title: IFN-alpha beta and self-MHC divert CD8 T cells into a distinct differentiation pathway characterized by rapid acquisition of effector functions
  publication-title: J Immunol
  doi: 10.4049/jimmunol.1001140
– volume: 145
  start-page: 2297
  issue: 11
  year: 2000
  ident: ppat.1012128.ref026
  article-title: Full-length sequence of a Canadian porcine reproductive and respiratory syndrome virus (PRRSV) isolate.
  publication-title: Arch Virol
  doi: 10.1007/s007050070022
– volume: 27
  start-page: 493
  issue: 3
  year: 1938
  ident: ppat.1012128.ref083
  article-title: A SIMPLE METHOD OF ESTIMATING FIFTY PER CENT ENDPOINTS.
  publication-title: American Journal of Epidemiology
  doi: 10.1093/oxfordjournals.aje.a118408
– volume: 64
  start-page: 33
  issue: 1
  year: 2023
  ident: ppat.1012128.ref054
  article-title: Identification of Parameters Representative of Immune Dysfunction in Patients with Severe and Fatal COVID-19 Infection: a Systematic Review and Meta-analysis
  publication-title: Clin Rev Allergy Immunol
  doi: 10.1007/s12016-021-08908-8
– volume: 25
  start-page: 50
  issue: 2
  year: 2000
  ident: ppat.1012128.ref046
  article-title: A novel superfamily of predicted cysteine proteases from eukaryotes, viruses and Chlamydia pneumoniae
  publication-title: Trends Biochem Sci
  doi: 10.1016/S0968-0004(99)01530-3
SSID ssj0041316
Score 2.469895
Snippet Porcine reproductive and respiratory syndrome virus (PRRSV) is known to suppress the type I interferon (IFNs-α/β) response during infection. PRRSV also...
Porcine reproductive and respiratory syndrome virus (PRRSV) is known to suppress the type I interferon (IFNs-[alpha]/[beta]) response during infection. PRRSV...
SourceID plos
doaj
pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage e1012128
SubjectTerms Adaptive immunity
Alveoli
Amino acids
Analysis
Animal diseases
Animals
antagonists
Antibodies
B cells
Bacteria
Bacterial infections
Betaarterivirus suid 2
Biological response modifiers
Biology and Life Sciences
Care and treatment
Chemokines
Coronaviruses
Cytokines
Diagnosis
disease severity
domain
Gene expression
Gene mutations
genes
Genetic aspects
genetic engineering
Genetic modification
Genetically modified organisms
Genetics
Genomes
Health aspects
Immunology
Infection
Infections
Inflammation
Interferon
interferons
Leucine
Livestock farms
Localization
Lymphocytes
Macrophages
Medical research
Medicine and Health Sciences
Medicine, Experimental
mixed infection
Mutants
Mutation
N gene
NF-κB protein
nuclear localization signals
nucleocapsid
Nucleocapsids
Pathogens
phenotype
Phenotypes
Porcine reproductive and respiratory syndrome
Pork industry
Proteins
Respiratory diseases
Respiratory tract diseases
reverse genetics
Signal transduction
Swine
vaccines
Viral diseases
Viral infections
viral nonstructural proteins
Viremia
Virus diseases
Viruses
β-Interferon
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9RADB6hSkhcEO8uFDQgJE6h2cz7uCCqgkQPQKXeonmFVt1NVpsEsT-S_4Sdx6pBhV64ZjyWZuyxPRn7MyGvtbdCOq6TAN4hQYypxAhXJNpZplXBZNHhzH4-kcen_NOZOLvS6gtzwnp44H7jDjl4QK64CVmqeWFS47m0aRTWMy9iVzydgc8bL1O9DQbL3DU9xaY4iWJSDkVzTM0PBxm9Xa9tBx8NtltPnFKH3b-z0HvrZVVfF37-mUV5xS0d3SN3h3iSLvp13Ce3YvmA3O47TG4fkl8LOtY-LrcUsTTLFqLLQEPVumVMVi12EaZVQSEOxzd2iiiXHQgsmEFqywAfdo_xdMQ3oD8uNm2dZLQ5tw3wijUtq4bCzNUauMHxiD-HDNuyY76pQJNB-VY9H79tqktMuKd9mST1VTKmhZUU_w1TS2u8qwcL5Ng2uQJNf0ROjz58e3-cDB0cEi-NaMDGOxULHZ1KTcEthhPCpSEGw5xkPvVMSG7mLNjCARmz2ILU62iyALoSA3tM9sqqjPuESgjt5oW3Oi0Edz41oABwF5JOm8hdyGaEjSLM_QBvjl02lnn3ZqfgmtNLJEfB54PgZyTZzVr38B430L9D7djRIjh39wFUNh9UNr9JZWfkFepWjvAbJeb3fLdtXecfv57kC6U1k4ip_1eiLxOiNwNRUcFivR1qKmDLENZrQnkwoQQj4ifD-6jn45rrHG6SZo4FeQpmjrp__fDL3TAyxZy9MlYt0oCvUBmT6T9owOFKY4TiM_KkP067vWVacJUJGNGTgzbZ_OlIeXHeIaQjDiLw5U__h7iekTsZUGDiYaYPyF6zaeNziEQb96IzOr8BbT2K_A
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1Lb9QwELagCIkL4t2FggxC4hTIxo4fJ1QQVUGiB6BSb5HtOG3FNl42CaI_kv_ETOIEgkq5xp9HiWc8ntjjbwh5rpzJheUqKWF1SJBjKtG5rRJlDVOyYqLqeWY_Hoj9Q_7hKD-KG25NTKscfWLvqMvgcI_8FYS2eok3hOTr9bcEq0bh6WosoXGVXEPqMkzpkkfTDxf45770KZbGSSQTIl6dY3L5Kmrq5XptehJp8OBqtjT1DP6Tn95ar0JzURD6dy7lH4vT3i1yM0aVdHcwg9vkiq_vkOtDncnzu-TnLh1vQK7OKTJq1h3EmCUtQ2dXPjnrsJYwDRWFaBxP2ilyXfZUsOAMqalLeDAdydOR5YB-P910TZLR9sS0IMs3tA4thZ5na5AGk8T_iHm2dS98E8CewQTPBjnuvA1fMe2eDpclqQvJmBxWU9whpoY2-MdeGoBj8eQA9n6PHO69-_J2P4l1HBIndN6Cp7fSV8pbmeqKGwwqcpuWvtTMCuZSx3LB9ZKVprIAYwYLkTrldVaCxfiS3Sdbdaj9NqECArxl5YxKq5xbl2rjIKDiwirtuS2zBWGjCgsXSc6x1saq6E_uJPzsDBopUPFFVPyCJFOv9UDy8R_8G7SOCYsU3f2DsDku4owvOIRuXHJdZqnilU6148KkPoc3drnPlwvyDG2rQBKOGrN8jk3XNMX7zwfFrlSKCWTW_yfo0wz0IoKqAB_rTLxZAUOG5F4z5M4MCa7EzZq30c7Hb26K35MOeo62f3Hz06kZhWLmXu1DhxhYMWTGRHoJBpZdoXUu-YI8GKbTNLZM5VxmObSo2USbDf68pT496XnSkQ0R5PKHl7_7I3IjA1VhYmGmdshWu-n8Y4g0W_ukdye_AEcJg5s
  priority: 102
  providerName: ProQuest
Title A clinically attenuated double-mutant of porcine reproductive and respiratory syndrome virus-2 that does not prompt overexpression of proinflammatory cytokines during co-infection with a secondary pathogen
URI https://www.ncbi.nlm.nih.gov/pubmed/38547254
https://www.proquest.com/docview/3069183357
https://www.proquest.com/docview/3022572360
https://www.proquest.com/docview/3153699574
https://pubmed.ncbi.nlm.nih.gov/PMC11003694
https://doaj.org/article/41024749d2084f909c46a0e5ac3c5e51
http://dx.doi.org/10.1371/journal.ppat.1012128
Volume 20
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwELb6EBIXxLsLZWUQEqdU2diO7QNCLWpVkFqhQqXeIttx2qrbZNkkqPsj-U_M5CWCWhDXeDxKxvNyPP6GkLfKGRFbroIUokOAGFOBFjYLlDVMyYzFWYMze3QcH57yz2fibI30PVs7AZa3bu2wn9Tpcr5z8331AQz-fdO1Qc76STuLhWkAocEbq3WyCbFJoqke8eFcATx20wwVm-UEkkneXaa7i8soWDWY_oPn3ljMi_K2tPTP6srfwtXBQ_KgyzPpbqsYj8iazx-Te23nydUT8nOX9nci5yuKGJt5DVlnStOitnMfXNfYXZgWGQXR4Nk7RfTLBhwW3CM1eQoPhkN62uMe0B-Xy7oMIlpdmAp4-ZLmRUVh5vUCuIHZ-Juu8jZvmC8LkDko5XXLx62q4goL8Wl7fZK6IujLxXKK_4ypoSXu4VMD5NhOuQALeEpOD_a_fTwMus4OgYu1qMD3W-kz5a0MdcYNphnChqlPNbMxc6FjIuZ6xlKTWSBjBluTOuV1lIIO-ZQ9Ixt5kfstQmNI-WaZMyrMBLcu1MZBisVjq7TnNo0mhPVLmLgO9hy7b8yT5ixPwvanXZEEFz7pFn5CgmHWooX9-Af9HmrHQIug3c2DYnmedD4g4ZDMccl1GoWKZzrUjscm9ALe2AkvZhPyBnUrQViOHOt-zk1dlsmnr8fJrlSKxYi1fyfRyYjoXUeUFfCxznR3LUBkCPc1otweUYJzcaPhLdTz_pvLBHaYeoYX9STM7HX_9uHXwzAyxVq-3Bc10kAMkRGLw7_QQCCOtRaST8jz1pwG2TIluIwEjKiRoY2EPx7JLy8a5HTERwS-_MV_Lu9Lcj-CtcPaw0htk41qWftXkIxWdkrW5Zmcks29_eMvJ9Pml8608Tm_AK8Wkww
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELbKVgguiHcXChgE4hSajZ3EPiC0hVZb2q5QaaXegu04bcVusmwSYP8U_4T_xEweC0GlnHqNJ6Mk84w98w0hz4VRfqC5cGKIDg5iTDnS14kjtGIiTFiQVDiz--NgdMTfH_vHK-RH2wuDZZWtT6wcdZwZ3CPfgNRWDrBDKHwz--Lg1Cg8XW1HaNRqsWsX3-CXLX-98w7k-8LztrcO346cZqqAYwLpF-B3dGgTYXXoyoQrDHG-dmMbS6YDZlzD_IDLAYtVooGMKRyLaYSVXgzPb2MGfK-QVc7gV6ZHVje3xh8OWt8PEaEatorDeJyQBUHTrMfCwUajG69mM1XBVkPMEJ1gWM0MWEaG3myS5eelvX9Xb_4RDrdvkhtNHkuHteLdIis2vU2u1pMtF3fIzyFtey4nC4oYnmkJWW1M46zUE-tMS5xeTLOEQv6PZ_sU0TUr8Flwv1SlMVxYFgHQFleBfj2bl7nj0eJUFcDL5jTNCgp3TmfADczSfm8qe9OK-TwDCwKln9Z8zKLIPmOhP63bM6nJnLYcLaW4J00VzXGPIFZAjuOaM7Cwu-ToUmR8j_TSLLVrhAaQUg4So4Sb-FwbVyoDKRwPtJCW69jrE9aKMDINrDpO95hE1VlhCL9XtUQiFHzUCL5PnOVdsxpW5D_0m6gdS1oEBa8uZPOTqPExEYdkkYdcxp4reCJdaXigXOvDExvf-oM-eYa6FSHsR4p1RSeqzPNo5-M4GoZCsACx_P9JdNAhetkQJRm8rFFNLwd8MoQT61CudyjBeZnO8hrqefvOefTbzOHOVvfPX366XEamWCuY2qxEGohRoQf2eQENBPpASj_kfXK_Nqflt2XC56Hnw4roGFrn43dX0rPTCpkd8ReBL39w8bM_IddGh_t70d7OePchue6B2LCs0RPrpFfMS_sI8txCP26cCyWfLtuf_QKxHcMw
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELZKEYgL4t2FAgaBOIVm4_cBoUKpWgoVAir1FhzHaSu2ybJJgP1r_Af-EzN5LASVcuo1Ho_izNPO-BtCHmlnhUy4DlKIDgFiTAVGJFmgE8u0ypjMGpzZt7tya4-_3hf7S-RHfxcGyyp7n9g46rRweEa-BqmtGeMNIbWWdWUR7zY2n0-_BNhBCv-09u00WhXZ8fNvsH0rn21vgKwfR9Hmq48vt4Kuw0DgpBEV-KBE-Uz7RIUm4xbDnUjC1KeGJZK50DEhuRmz1GYJkDGLLTKd9iZKYS0-ZcD3HDmvmBijjan9xWYPYkPTdhXb8gSKSdld22NqvNZpydPp1DYA1hA99CAsNt0DFjFieTopypMS4L_rOP8IjJtXyOUuo6XrrQpeJUs-v0YutD0u59fJz3Xa376czCmieeY15LcpTYs6mfjguMY-xrTIKOwE8C8_RZzNBoYWHDG1eQoPFuUAtEdYoF-PZnUZRLQ6tBXw8iXNi4rCzOMpcAMD9d-7Gt-8YT4rwJZA_Y9bPm5eFZ-x5J-2FzWpK4K-MC2neDpNLS3xtCC1QI6NmwuwtRtk70wkfJMs50XuVwiVkFyOM2d1mAmeuNBYB8kcl4k2nidpNCKsF2HsOoB17PMxiZu_hgo2Wq1EYhR83Al-RILFrGkLMPIf-heoHQtahAdvHhSzg7jzNjGHtJErbtIo1DwzoXFc2tALeGMnvBiPyEPUrRgBQHI0pQNbl2W8_WE3XldaM4mo_v8kej8getIRZQUs1tnuVgd8MgQWG1CuDijBjbnB8Arqeb_mMv5t8DCz1_2Thx8shpEpVg3mvqiRBqKVipgMT6GBkC-NEYqPyK3WnBbflmnBVSRgRA8MbfDxhyP50WGD0Y5IjMCX3z793e-Ti-DF4jfbuzt3yKUIpIb1jZFeJcvVrPZ3IeGtknuNZ6Hk01m7sl8VvsYA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+clinically+attenuated+double-mutant+of+porcine+reproductive+and+respiratory+syndrome+virus-2+that+does+not+prompt+overexpression+of+proinflammatory+cytokines+during+co-infection+with+a+secondary+pathogen&rft.jtitle=PLoS+pathogens&rft.au=Su%2C+Chia-Ming&rft.au=Kim%2C+Jineui&rft.au=Tang%2C+Junyu&rft.au=Hung%2C+Yu+Fan&rft.date=2024-03-28&rft.issn=1553-7374&rft.eissn=1553-7374&rft.volume=20&rft.issue=3&rft.spage=e1012128&rft_id=info:doi/10.1371%2Fjournal.ppat.1012128&rft.externalDBID=n%2Fa&rft.externalDocID=10_1371_journal_ppat_1012128
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1553-7374&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1553-7374&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1553-7374&client=summon